Status:
UNKNOWN
Methylprednisolone Addition in IVF Treatment of Infertile Couples
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
BioGenesis
HRG
Conditions:
In Vitro Fertilization
Eligibility:
FEMALE
21-36 years
Phase:
PHASE4
Brief Summary
Hypothesis to be tested is whether follicular addition of Methylprednisolone can efficiently control late follicular progesterone rise during IVF treatment
Detailed Description
The aim is to investigate any potential advantages of adding cortisone supplementation from the follicular phase onwards with regard to premature luteinization, oocyte quality, embryo quality and preg...
Eligibility Criteria
Inclusion
- less than 36, more than 10 antral follicles, FSH\<12
Exclusion
- endometriosis stage III\&IV,
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01220791
Start Date
January 1 2009
End Date
December 1 2011
Last Update
October 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biogenesis
Thessaloniki, Pylaia, Greece, 55536